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ABSTRACT 
Objective 
The risk of repetition of deliberate self-harm (DSH) peaks in the first seven days after a DSH episode. However, thus far no studies 
have examined the risk factors for repeating DSH during this short-term period. We aimed to investigate the effects of socio-
demographic factors, self-harm method, and mental health factors in adolescents (10-19 years old) and young adults (20-29 years old). 
Methods  
We used data linkage of population-wide administrative records from hospital inpatients and emergency departments to identify all 
the DSH-related episodes that occurred in adolescents and young adults in Western Australia from 2000 to 2011. Logistic regression 
with GEE was used for the analyses. 
Results 
The incidence of repeating DSH within the first seven days after an index episode was 6% (403/6,768) in adolescents and 8% 
(842/10,198) in young adults. Socio-demographic risk factors included female gender and socioeconomic disadvantage. Compared to 
non-poisoning, self-poisoning predicted increased risk of repeating a DSH episode in males, but not in females. Borderline 
personality, impulse-control, and substance use disorders diagnosed within one week before and one week after an index DSH 
episode conferred the highest risk, followed by depressive and anxiety disorders. Having a preceding DSH episode up to seven days 
before an index episode was a strong predictor for the future repetition of a DSH episode.  
Conclusions  
Having a repeated DSH episode within the first seven days was related to a wide range of factors present at an index DSH episode 
including socio-demographic characteristics, DSH method, and co-existing psychiatric conditions. These factors can inform risk 
assessments tailored to adolescents and young adults respectively to reduce the repetition of DSH within a short but critical period, 
potentially contributing to reduce the repetition of DSH in the long term.  
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TEXT 
INTRODUCTION 
Deliberate self-harm (DSH) refers to behaviours performed directly and intentionally to cause physical or psychological destruction to 
oneself, regardless of suicidal intent (Hawton et al., 2012b). It is a major public health issue affecting 17% of people aged between 
15-24 years (Muehlenkamp et al., 2012) and causing one in five deaths in this population (Patton et al., 2009). School-based survey 
studies found that approximately one in eight teenage students with DSH behaviours sought medical or emergency care (Madge et al., 
2008, Hawton et al., 2002).  
Studies based on medical records (e.g. hospital and emergency department) revealed that 15-16% of patients presenting for DSH had 
a non-fatal repeated DSH act within the first year following the initial clinical episodes, and 2% had a fatal repeated DSH act (Owens 
et al., 2002, Carroll et al., 2014). The repetitive nature of DSH has a strong link with subsequent suicidal death (Hawton et al., 2012b), 
and it also places a great burden on health and social care system (Sinclair et al., 2011). Repetition of DSH may occur more often in 
adolescents and young adults than people of other age groups (Zahl and Hawton, 2004).  
Due to the “hidden” nature of DSH behaviours, a person’s DSH behaviour usually becomes known by health professionals, when the 
person presents at a clinical setting such as emergency department for treatment of injuries. Therefore, clinical setting constitutes an 
important place where frontline services of intervention should be provided to prevent the repetition of DSH behaviours.  
Previous studies that examined the risk factors for re-attendance to an emergency department or other clinical settings focused on the 
repetition of a DSH episode at least 30 days after the initial DSH episode. From these studies, a range of factors have been associated 
with an increased risk of repeating DSH. These risk factors include socioeconomic deprivation and social fragmentation (Gunnell et 
al., 1995, Hawton et al., 2001), having psychiatric disorders and drug/alcohol abuse (Olfson et al., 2013, Beghi et al., 2013, Vajda and 
Steinbeck, 2000). Self-harm method and the degree of suicidal intent were also linked to repeating DSH (Hawton et al., 2012a). 
Further, having repeated DSH behaviours in the past is strongly predictive of repeating DSH in the future (Larkin et al., 2014). 
Evidence based on emergency and hospital services shows that of people with a repeated DSH episode that occurred within the first 
year after their initial DSH episodes, more than 10% had a repeated DSH episode within the first week (Gilbody et al., 1997, Kapur et 
al., 2006). This incidence was found to be higher than the incidence in each subsequent week (Gunnell et al., 2002), indicating that the 
first seven days after a DSH clinical episode is a critical window for interventions to be carried out to reduce the early repetition of 
DSH behaviours.  
Further, seven days following a discharge from an acute psychiatric unit is regarded as a vulnerable period for patients with mental 
health problems in Australian public mental health services (NMHWG Information Strategy Committee Performance Indicator 
Drafting Group, 2005). It also emphasises that continuity of care involving responsive community follow-up during this immediate 
post-discharge period plays an essential part in maintaining a patient’s clinical and functional stability and in minimising the need for 
early readmission.  
A better understanding of the risk factors related to repeating DSH within the first seven days can improve the capacity of community 
care services in delivering targeted and effective risk assessment and risk management for adolescent and young adult patients at high 
risk of repeating DSH. However, thus far there has been a lack of studies with a specific focus on the risk factors for repeating DSH 
within the first seven days. 
In this study, we focused on the repetition of DSH within the first seven days following an index DSH episode in adolescents (10-19 
years old) and young adults (20-29 years old). We used data linkage of population-wide administrative health records in Western 
Australia (WA) to examine three sets of risk factors: socio-demographic characteristics, self-harm method, and mental health 
conditions. Because risk factors, pattern of self-harm method, and suicidal intent of DSH behaviours differ between adolescents and 
young adults (Hjelmeland and Groholt, 2005), we conducted separated analyses for these two groups of population. Given that the 
risk factors for DSH vary by gender (Hawton, 2000), we also explored the gender-specific differences in the effects of each risk 
factor.  
METHODS 
Linked Health Records 
This study was based on the data linkage of population-wide administrative health records routinely collected in WA. Raw records 
relating to the same person were linked using probabilistic matching method by the WA Data Linkage Branch (Holman et al., 2008). 
Variables for linking records included name, sex, date of birth, home address, and other unique identifiers such as hospital unique 
medical record number. Clerical checking of additional information is undertaken for possible matches that fall within a “grey area” 
between definite matches and definite non-matches. During the linkage process, de-identified linkage keys were generated for each 
unique person, and we merged the records across different data collections using these linkage keys. By 1996, the proportion of 
invalid and missed links were both estimated at 0.11% (Holman et al., 1999, Tromp et al., 2011). More information about the data 
linkage in WA is on the website: http://www.datalinkage-wa.org/data-linkage/data-collections. 
Records used for this study were sourced from the Emergency Department Data Collection (EDDC) including emergency department 
contacts in all hospitals under contract with the WA government, the Hospital Morbidity Data System (HMDS) including inpatient 
admissions (including mental health inpatients) in all hospitals in WA, the Mortality Register including all deaths registered in WA, 
and the Mental Health Information System (MHIS) including mental health outpatients in public hospitals. Data collections date back 
to 2000 and earlier, except for emergency data which include records from 2002 onwards.  
Study sample  
We included all DSH-related records of emergency contacts, hospital inpatient admissions, and deaths in adolescents (10-19 years 
old) and young adults (20-29 years old) between the year 2000 and 2011 (inclusive). 
Identification of Valid Index DSH Episodes 
We identified DSH-related records according to the diagnosis codes of the International Statistical Classification of Diseases and 
Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM). The codes are shown in the Supplementary Table 1. 
We followed the convention to include ‘undetermined intent’ (ICD-10-AM codes: Y10-Y34) to take into account possible 
misclassifications of DSH in clinical settings (Cantor et al., 2001). We referred to all the diagnostic fields in the HMDS, the EDDC, 
the MHIS, and the Mortality Register datasets to identify DSH-related records. We also referred to two variables contained in the 
EDDC: “presenting problem” and “human intent of injury”, which were coded in different systems from the ICD-10-AM. For an 
improved validity of the identification of DSH episodes in the EDDC data, only the episodes assigned with an injury-related ICD code 
(excluding injuries solely induced by assault) in addition to a DSH-related code were included in the analyses. This is because that we 
considered the presence of an injury as an important indicator for an actual DSH act. 
The aim of this study was to explore the risk factors present at the time of a DSH episode that predicted the repetition of a DSH 
episode. We therefore identified the repetition of DSH within the first seven days following a valid index episode, rather than the first 
episode for each unique person. 
A valid index episode was defined according to the following three criteria. First, if a DSH episode occurred less than seven days 
before the person’s death or the end of the study period (i.e. 31st Dec 2011) and this episode was not followed by any subsequent DSH 
episodes, such an episode was not considered as a valid index episode (removing 38 records). This criterion ensures that there were at 
least seven days after each valid index episode to allow for the identification of a repeated DSH episode. Second, a death record was 
not considered as a valid index episode (removing 898 death records), because no subsequent DSH episodes can occur. Last, when a 
person was transferred from an emergency department to an inpatient care unit following the same DSH behaviour, we considered 
such “transfer-bonded” episode pairs as one valid episode. There were a total of 1,365 transfer-bonded episode pairs, and we only 
used the inpatient episodes for the data analysis, because inpatient data were generally thought to have a better quality than emergency 
data.  
In total, we identified valid 16,966 DSH episodes. Of these episodes, 13,336 (78.60%) were identified from the emergency data (i.e. 
EDDC), and 3,595 (21.19%) from the hospital inpatient data (i.e. HMDS). The remaining episodes were from mental health episodes 
(i.e. MHIS). For emergency episodes, we used the “presentation date” as the starting time point to determine the seven-day window 
for the repetition. For hospital inpatient episodes, we used the “admission date”, rather than the discharge date to determine the seven-
day repetition window. More information is in the Supplementary Table 2. 
Identification of Risk Factors 
Socio-demographic factors 
We identified socio-demographic factors, which included sex, Aboriginality, neighbourhood socioeconomic disadvantage, and 
remoteness of residence in each index DSH episode (Figure 1). The indices for neighbourhood socioeconomic disadvantage and 
remoteness of residence are developed by the Australian Bureau of Statistics (Australian Bureau of Statistics, 2008, GISCA - The 
National Centre for Social Applications of GIS The University of Adelaide, 2004). The index score of neighbourhood socioeconomic 
disadvantage combines a range of factors such as household income, educational attainment, and employment status of people 
residing in a small area that contains approximately 250 dwellings (Australian Bureau of Statistics, 2008). We used the quartiles of 
the score of the neighbourhood socioeconomic disadvantage, with a lower quartile representing a higher level of socioeconomic 
disadvantage. The remoteness of residence reflects the geographic accessibility to services in an area (unrelated to socioeconomic 
status, rurality and population size) (GISCA - The National Centre for Social Applications of GIS The University of Adelaide, 2004). 
This index contains four levels of area, which are major cities, inner regional areas, outer regional areas, and remote/very remote 
areas. 
Self-harm method 
We used the ICD-10-AM external cause codes and the presenting problem codes (EDDC) to identify self-harm method 
(Supplementary Table 1). First, we classified all episodes into self-poisoning versus non-poisoning episodes. For non-poisoning 
episodes, the predominant method was self-cutting. Second, for all self-poisoning episodes, they were further classified into three sub-
categories: self-poisoning with drug/medication, with other substance, and with unspecified substance. Last, all drug/medication-
related self-poisoning episodes were classified into illicit drug use versus non-illicit drug use. 
Mental health conditions 
Co-existing psychiatric disorders 
Previous studies have found that co-existence of severe psychiatric disorders at the time of DSH behaviours was a strong predictor for 
the future repetition of DSH behaviours (Hawton et al., 2003). Further, there was possibility that patients’ pre-existing psychiatric 
disorders were discovered or diagnosed because of their presence at a clinical setting for DSH behaviours. Therefore, we identified 
any records of psychiatric diagnosis within seven days before and seven days after a valid index DSH episode as a proxy for the co-
existence of psychiatric disorders. We identified co-existing psychiatric disorders from the MHIS and HMDS data according to ICD-
10-AM codes (Supplementary Table 1). We also identified major types of psychiatric disorders, including substance use disorders, 
psychotic disorders, bipolar disorders, depressive disorders, anxiety disorders, stressor-related disorders, impulse-control disorders, 
and borderline personality disorder (BPD).   
Having a preceding DSH episode up to seven days before an index episode 
Additionally, we were interested in whether and how having a preceding DSH episode up to seven days before an index episode may 
predict the future repetition up to the next seven days following an index episode. This recent history may be an important message 
for mental health crisis and hence may strongly predict repeating DSH within the next seven days.  
Data Analysis 
The prevalence of repeating DSH within the first seven days following an index episode was calculated for each risk factor. Logistic 
regression analysis was used to estimate the crude and adjusted odds ratios (ORs) for repeating DSH associated with each factor. 
Crude ORs were derived from univariate logistic analysis and adjusted ORs were generated from multivariate logistic analysis 
including all the factors examined in this study. 
To adjust for the clustering of DSH episodes within a same person, logistic regression analyses with GEE (generalised estimating 
equations) were conducted. Because the association between DSH episodes may decay with an increasing interval between the 
episodes, we specified the first-order autoregressive structure for the working correlation matrix (Fitzmaurice et al., 2004). Standard 
errors of regression coefficients were obtained from the empirical estimation. Zeger et al. (1998) found that the empirical estimation 
can yield robust standard errors even when the working correlation matrix has been mis-specified.  
Furthermore, we used multivariate negative binomial regression analysis to estimate the association between having a repeated DSH 
episode within the first seven days following an index episode (binary) and the total number of valid DSH episodes. We included the 
Pearson scale parameter to address over-dispersion.  
All the analyses were conducted separately for adolescents and young adults, as well as separately for males and females. We used 
generalized score tests for Type III GEE analysis to examine the significance of the differences in the effects of the risk factors 
between adolescents and young adults, as well as between males and females. P value < 0.05 was considered as statistical significance 
for all the analyses. Data management and analyses were carried out using SAS® (EG) statistical software version 6.1 (SAS Institute 
Inc., Cary, NC, USA). 
RESULTS 
Table 1 shows that a total of 6768 valid DSH episodes in adolescents (2123 in males, 4645 in females) and 10198 valid episodes in 
young adults (4450 in males, 5748 in females) were identified between the year 2000 and 2011. The prevalence of repeating DSH 
within the first seven days after a DSH episode was 8.26% (842 repeated episodes) in young adults, which was significantly higher 
(p<0.0001) than the prevalence of 5.95% (403 repeated episodes) in adolescents.  
In the following paragraphs, we showed the effects of all the factors for males and females separately in the Table 2. Because the 
effects of mental health related factors were also found to differ significantly between adolescents and young adults, we further 
showed the effects for adolescents and young adults separately in the Table 3. 
Socio-demographic risk factors 
Table 2 shows that the odds of repeating DSH within the first seven days following a DSH episode in females were higher than males 
by 53% (95%CI:26-87%). Non-Aboriginality was a significant risk factor for females only, and the odds of repeating DSH within 
seven days in non-Aboriginal females was higher than Aboriginal females by 85% (95%CI:20-186%) .  
Compared to living in the least disadvantaged areas, living in the most disadvantaged areas was associated with a 38% (95%CI:8-
77%) increase in the odds of repeating DSH within seven days following a DSH episode. The trend effect showed an average of 9% 
(95%CI:1-19%) increase in the odds of repeating DSH within seven days with each increment in the quartile scale of socioeconomic 
disadvantage. Compared to residence in other regions, residing in remote areas was associated with a significant decrease in the odds 
of repeating DSH within seven days. 
Self-harm method  
Table 1 shows that self-poisoning was involved in around two thirds of all the valid DSH episodes in females, and it was less common 
in males (45%). Drug/medication was ingested in nearly 90% of all self-poisoning episodes.  
Table 2 shows that compared to non-poisoning episodes, self-poisoning episodes were associated with a significantly increased odds 
of repeating DSH within seven days in males (aOR=1.43,95%CI:1.12-1.81), but a significantly decreased odds in female adolescents 
(aOR=0.66,95%CI:0.50-0.87), and had no significant effect in female young adults. Table 2 further shows that for self-poisoning 
episodes, drug/medication use was associated with a twofold increase in the odds of repeating DSH within seven days 
(aOR=1.92,95%CI:1.25-2.97), compared to no drug/medication episodes.  
For self-poisoning episodes by drug/medication, we did not find a significant difference in the effects of illicit drug use versus non-
illicit drug use on repeating DSH within seven days (aOR= 0.89,95%CI:0.62-1.29). 
Mental health related risk factors 
Psychiatric disorders at the time of an index DSH episode 
Table 1 shows that 45.7% of valid index DSH episodes in adolescents and 48.8% in young adults occurred with a psychiatric 
diagnosis recorded within seven days before and seven days after a DSH episode. For both adolescents and young adults, stressor-
related disorders, depressive disorders, and substance use disorders were the most common psychiatric disorders. Borderline 
personality disorder (BPD) was common in females, particularly for female young adults. For males, impulse-control disorders were 
common for adolescents and psychotic disorders were common for young adults. 
Table 2 shows that having co-existing psychiatric diagnosis within one week before and one week after a DSH episode was associated 
with a 2.73-fold (95%CI:2.35-3.18) increase in the odds of repeating DSH within seven days, compared to having no psychiatric 
diagnosis. Table 3 shows that the magnitude of this association was highest in male adolescents. 
Table 3 shows that having BPD within one week before and one week after a DSH episode was associated with a three-fold increase 
in the odds of repeating DSH within the first seven days, compared to not having a diagnosis of BPD. This association was equally 
strong in adolescents and young adults, but larger in females (aOR=3.37,95%CI:2.67-4.24) yet non-significantly (p=0.05) than in 
males (aOR=2.29,95%CI:1.63-3.22). The presence of stressor-related disorders also had a similar effect for adolescents 
(aOR=1.67,95%CI:1.26-2.21) and young adults (aOR=1.39,95%CI:1.11-1.74).    
Table 3 shows that having impulse-control disorders was associated with a four-fold increase in the odds of repeating DSH within 
seven days in male adolescents (aOR=3.91,95%CI:2.29-6.67), which doubled the increase in the odds for female adolescents 
(aOR=2.00,95%CI:1.24-3.25). However, this gender-specific difference in the effects did not reach statistical significance (p=0.10). 
Having depressive disorders was related to a 1.72-fold increase in the odds of repeating DSH in adolescents (aOR=1.72,95%CI:1.23-
2.41), but not in young adults (aOR=1.14,95%CI:0.92-1.42). 
Having substance use disorders within one week before and one week after a DSH episode only had a significant effect in male young 
adults (aOR=2.24,95%CI:1.65-3.05), which was significantly higher than the effects in females and male adolescents (p<0.01).  
Having psychotic disorders did not show to have a significant effect on repeating DSH within seven days. 
Having a preceding DSH episode up to seven days before an index episode 
Having a preceding DSH episode in the past seven days prior to a DSH episode was associated with a 2.4-fold (95%CI:1.91-3.00) 
increase in the odds of repeating DSH within the next seven days of a DSH episode. Additionally, individuals who had a repeated 
DSH episode within the first seven days following a DSH episode had a total number of DSH episodes, which was triple the number 
of those who did not (p<0.0001). This association was significantly stronger (p<0.0001) in females (3.6-fold) than males (2.2-fold).  
DISCUSSION 
To our knowledge, there was no studies with a specific focus on risk factors contributing to repeating DSH within the first seven days 
following a DSH episode in adolescents and young adults. In this study, we showed that socio-demographic factors, DSH method, 
mental health conditions at the time of a DSH episode were all associated with the risk of repeating DSH within the first seven days in 
adolescents and young adults. Our results also displayed several significant differences in the effects of these risk factors between 
adolescents and young adults, as well as between males and females. These findings can inform risk assessments aimed at reducing 
the repetition of DSH within a short but critical period, potentially contributing to reduce the repetition of DSH in the long term.  
We found that young adults were at a higher risk for repetition of DSH episodes than adolescents, and females at higher risk than 
males. Previous studies also found that young adults and females were both at high risk of repeating DSH over the period longer than 
seven days (Perry et al., 2012).  
Living with socioeconomic disadvantage predisposes a person to initiate and maintain DSH behaviours (Payne et al., 2009). Our 
findings further showed that higher socioeconomic disadvantage was related to increased risk of repeating a DSH episode within the 
first seven days following a DSH episode. This may be partially attributed to mental health issues and victimisation that accompany 
socioeconomic disadvantage, which hasten the recurrence of DSH episode. Further, it was suggested that people living with a higher 
socioeconomic disadvantage may have a lower access to mental health services and a poorer quality of care (e.g. lower volumes of 
services or less highly trained service providers) (Meadows et al., 2015).  
In the current clinical practice, self-harm method and substance use are commonly used in the risk assessment for repeated DSH 
episodes (Cooper et al., 2006, Corcoran et al., 1997, Steeg et al., 2012). Our study showed that different DSH methods may 
differently predict the risk of repeating a DSH episode within the first seven days for males and females. Most notably, compared to 
non-poisoning methods, self-poisoning was linked to a decreased risk in female adolescents, but an increased risk in male adolescents 
and young adults. Previous studies found that self-poisoning was related to a decreased risk of repeating DSH (Hawton et al., 2012a, 
Bilen et al., 2011); however, these findings were based on combined samples including males and females despite the majority of the 
DSH episodes occurring in females, thus masking a potentially important gender difference. Additionally, we did not find that illicit 
drug use increased the repetition of DSH within the first seven days, although it may predict repeating DSH in a longer term (Haw et 
al., 2007). 
A possible explanation for the decreased repetition of a DSH episode within the first seven days related to non-poisoning versus self-
poisoning method in males is that non-poisoning DSH method may very likely indicate DSH behaviours of more violent and lethal 
nature (e.g. cutting, exposure to gas) in males than in females (Harrison and Henley, 2014). Therefore, non-poisoning DSH methods 
may imply more serious resulting injuries that require critical and hence a longer period of hospitalised care in males, which may 
consequently delay the occurrence of a repeated DSH episode. This interpretation for the positive relationship between a non-
poisoning DSH method and reduced repetition of a DSH episode within the first seven days may also be applied to some other 
findings in this study. For example, repeating DSH was significantly reduced in remote areas in Australia, where highly lethal 
methods were more commonly used in DSH behaviours, compared to other areas (Harrison and Henley, 2014). Similarly, this may 
also explain the reduced repetition of a DSH episode observed in Aboriginal females, because violent methods were more commonly 
used in DSH behaviours among Aboriginal people than their non-Aboriginal peers, particularly for females (Harrison and Henley, 
2014).  
Our results showed that co-existing psychiatric disorders within one week before and one week after a DSH episode predicted highly 
increased risk of repeating DSH within the first seven days. We found that having BPD, impulse-control disorders (in adolescents), 
and substance use disorders (in male young adults) conferred the highest risks for repeating DSH within seven days. These disorders 
are marked by an impaired self-control of emotions, which predisposes a person to impulsive and aggressive behaviours, such as DSH 
(Evans et al., 1996). Substance use disorders only had a significant effect in male young adults, which underlines the need to provide 
drug and alcohol treatment services immediately after a DSH episode for a male with substance use disorders.  
Additionally, psychiatric disorders with more internalising symptoms such as depressive disorders (in adolescents) and anxiety 
disorders (in female young adults) also carried significant risks for repeating DSH within the first seven days. These internalising 
disorders, however, had a smaller effect than that of externalising disorders as discussed above, which may be because that 
internalising disorders have chronic than acute influence (McMillan et al., 2007, Hawton et al., 2003). We did not find strong 
evidence for a significant gender-specific differences in the effects of psychiatric disorders such as borderline personality disorders 
and impulse-control disorders. This may be due to small sample size for sub-groups of population (e.g. males for BPD). More 
research is needed to validate these gender differences. 
Finally, we found that people who had a preceding DSH episode at a clinical presentation were more likely to repeat a DSH episode 
in the next seven days. Additionally, we found that people who previously repeated a DSH episode within the first seven days were 
had three times more DSH episodes, compared to those with DSH behaviours but did not have a repeated DSH episode within seven 
days. These findings may have implied that to reduce the repetition of DSH within the first seven days is important to the prevention 
of repeating DSH in a longer period of time. 
Strengths and limitations 
The linkage of population-wide administrative health records has the following strengths. First, DSH episodes were drawn from 
whole population, thus a large sample size could be obtained for the examination of a low incidence event, i.e. DSH episode within 
seven days. Secondly, administrative data enable the exploration of a wide range of risk factors. Thirdly, the record linkage allows for 
longitudinal analysis, and the linkage of the records from multiple sources provides a more accurate and complete picture of the 
trajectory leading to the repetition of DSH. Fourthly, data were collected objectively using standardised clinical diagnoses (e.g. ICD-
10-AM codes) by clinical personnel, and this ensures the validity of the diagnosis of psychiatric disorders and the identification of 
DSH episodes and the self-harm methods.   
There were also some limitations in this study. First, approximately 80% of the DSH records were sourced from emergency 
departments and 20% from hospital inpatient units. Pharmaceutical data and records from general practice and private clinics were 
unavailable in the data linkage. Therefore, our findings are specifically generalisable to adolescents and young adults who presented 
at an emergency department, where the presenting DSH-related injuries and psychiatric disorders were more clinically critical. 
Second, while suicidal intent, stressful life event, and family dysfunction are important predictors for repeating DSH (Harriss et al., 
2005, Keeley et al., 2003), we were unable to include these factors in this study due to the lack of such information in the data 
linkage. Third, although we could identify a transfer to hospital inpatient care after an emergency episode, other health service use 
following the discharge from an emergency episode was unknown. This warrants an important direction in future studies about the 
types of healthcare service (e.g. long-term hospital inpatient care, community mental health service) that can deliver the most cost-
effective interventions in reducing the re-occurrence of DSH behaviours within the first seven days after an index episode. 
Implications 
A recent Danish study has demonstrated that psychosocial assessment and intervention are promising in reducing the risk of 
subsequent DSH behaviour and fatal outcomes of DSH both in the short-term and long-term for general population (Erlangsen et al., 
2015). Our study has found that socio-demographic factors, self-harm method, and mental health issues (e.g. co-existing psychiatric 
disorders and mental health crisis) were closely related to repeating DSH within the first seven days after a DSH episode. Therefore, 
these risk factors should be carefully considered in psychosocial assessments to predict and hence intervene the repetition of DSH 
within an immediate post-discharge period. Our results highlighted the need to focus on different factors in the risk assessment for 
adolescents and young adults, as well as for males and females. Before being discharged from an emergency department or hospital 
inpatient unit, patients should receive a systematic psychosocial assessment, responsive follow-up of drug and alcohol treatment if 
substance use problems are identified, and evaluation of mental health conditions such as co-existing psychiatric disorders and mental 
health crisis that is present within the past week of an index DSH episode. Further, social interventions and care targeted at reducing 
social and economic adversities and improving the access to health and social supports are vital for preventing the repetition of DSH 
in the short-term.  
Conclusion 
In this study, we demonstrated that socio-demographic factors, DSH method, and psychiatric conditions all predicted repeating DSH 
within the first week after an index DSH episode in adolescents and young adults. These factors have different impacts for adolescents 
and young adults, and for females and males. Our findings can inform the future development of psychosocial risk assessment tailored 
to adolescents and young adults aimed at reducing the repetition of DSH within a relatively short but critical period, which may also 
have the potential to reduce repeating DSH in the long term.  
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Psychiatric disorders  
 
Psychiatric disorders were identified within the period of up 
to 7 days before and 7 days after the index DSH episode 
from the HMDS and the MHIS data. 
Outcome 
A repeated DSH episode within the first 7 days after 
the index episode 
 
The outcome was identified within the first 7 days 
after the index DSH episode from the HMDS, the 
EDDC, the MHIS, and the Mortality data 
TABLE 
Table 1 Gender-specific number of the valid DSH episode and percentage for having a repeated DSH episode within the first 7 days 

















Total 6768 (5.95)1 2123 (4.05) 4645 (6.82) 10198 (8.26) 4450 (6.16) 5748 (9.88) 
Socio-demographic factors             
Gender             
    Male  2123 (4.05) --- --- 4450 (6.16) --- --- 
    Female 4645 (6.82) --- --- 5748 (9.88) --- --- 
Aboriginality             
    Non-Aboriginal  6312 (6.12) 1938 (4.13) 4374 (7.00) 9549 (8.46) 4111 (6.25) 5438 (10.13) 
    Aboriginal  456 (3.73) 185 (3.24) 271 (4.06) 649 (5.24) 339 (5.01) 310 (5.48) 
Neighbourhood disadvantage             
    Q1 (0%-25%) 1869 (7.17) 637 (5.34) 1232 (8.12) 3199 (9.10) 1509 (6.30) 1690 (11.60) 
    Q2 (25%-50%) 1527 (5.17) 497 (4.43) 1030 (5.53) 2525 (7.76) 1073 (6.90) 1452 (8.40) 
    Q3 (50%-75%)  1352 (7.03) 426 (3.29) 926 (8.75) 1909 (8.22) 753 (4.65) 1156 (10.55) 
    Q4 (75%-100%) 1737 (4.72) 449 (2.45) 1288 (5.51) 1969 (8.33) 769 (6.11) 1200 (9.75) 
    Missing 283 (4.59) 114 (4.39) 169 (4.73) 596 (5.70) 346 (6.65) 250 (4.40) 
Remoteness             
    Major cities  5649 (5.84) 1732 (3.64) 3917 (6.82) 8441 (8.65) 3581 (6.37) 4860 (10.33) 
    Inner regional areas 509 (6.48) 175 (6.29) 334 (6.59) 703 (7.25) 310 (4.52) 393 (9.41) 
    Outer regional areas 215 (11.63) 58 (10.34) 157 (12.10) 250 (7.60) 117 (5.13) 133 (9.77) 
    Remote and very remote areas 112 (1.79) 44 (2.27) 68 (1.47) 208 (3.85) 96 (3.13) 112 (4.46) 
    Missing 283 (4.59) 114 (4.39) 169 (4.73) 596 (5.70) 346 (6.65) 250 (4.40) 
Self-harm method             
Non-poisoning  2635 (6.30) 1165 (2.83) 1470 (9.05) 4271 (8.22) 2316 (5.35) 1955 (11.61) 
Self-poisoning 4133 (5.73) 958 (5.53) 3175 (5.80) 5927 (8.28) 2134 (7.03) 3793 (8.99) 
      Drug involved 3578 (6.01) 799 (5.76) 2779 (6.08) 5383 (8.43) 1862 (7.04) 3521 (9.17) 
          Non-illicit drug use 2843 (6.33) 596 (6.04) 2247 (6.41) 3974 (8.71) 1293 (7.50) 2681 (9.29) 
          Illicit drug involved 173 (4.62) 53 (7.55) 120 (3.33) 402 (9.20) 172 (5.81) 230 (11.74) 
          Unspecified drug 562 (4.80) 150 (4.00) 412 (5.10) 1007 (7.05) 397 (6.05) 610 (7.70) 
      No drug involved 281 (3.56) 88 (3.41) 193 (3.63) 327 (5.50) 173 (5.20) 154 (5.84) 
      Unspecified substance 274 (4.38) 71 (5.63) 203 (3.94) 217 (8.76) 99 (10.10) 118 (7.63) 
Mental health related factors             
Having psychiatric diagnosis within 7 days before and 7 days after an index DSH episode    
    Any psychiatric disorders 3094 (9.24) 820 (7.32) 2274 (9.94) 4979 (12.11) 1840 (8.97) 3139 (13.95) 
    Substance use disorders 577 (6.59) 248 (6.05) 329 (6.99) 1594 (13.05) 818 (11.86) 776 (14.30) 
    Psychotic disorders 103 (9.71) 41 (2.44) 62 (14.52) 500 (11.40) 301 (7.97) 199 (16.58) 
    Bipolar disorders 55 (21.82) 8 (37.50) 47 (19.15) 224 (10.71) 45 (4.44) 179 (12.29) 
    Depressive disorders 1034 (10.74) 224 (8.48) 810 (11.36) 1476 (12.47) 487 (9.03) 989 (14.16) 
    Anxiety disorders 216 (7.41) 50 (10.00) 166 (6.63) 357 (14.57) 134 (11.19) 223 (16.59) 
    Stressor-related disorders 1276 (10.42) 322 (8.70) 954 (11.01) 1822 (13.72) 608 (10.20) 1214 (15.49) 
    Impulse-control disorders 237 (13.50) 92 (13.04) 145 (13.79) 37 (8.11) 23 (4.35) 14 (14.29) 
    Borderline personality disorders 462 (19.26) 80 (12.50) 382 (20.68) 1471 (20.73) 176 (16.48) 1295 (21.31) 
DSH episode occurring up to 7 days before an index DSH episode        
    No 6367 (5.43) 2037 (3.78) 4330 (6.21) 9361 (7.22) 4177 (5.89) 5184 (8.29) 
    Yes  401 (14.21) 86 (10.47) 315 (15.24) 836 (19.86) 272 (10.29) 564 (24.47) 
1 The statistics A and B in the form A(B) represent the number of the valid DSH episodes and the percentage of the valid episodes that were followed 
by a repeated DSH episode within the first 7 days after the valid episode.  
Table 2 Gender-specific association between having a repeated DSH episode within the first 7 days after an index DSH episode and socio-demographic factors, self-harm 
method, and mental health related factors in adolescents and young adults (10-29 years old) 
Factor 
All Male  Female P value 
for gender 
difference 
OR (95%CI) aOR (95%CI) OR (95%CI) aOR (95%CI) OR (95%CI) aOR (95%CI) 
Socio-demographic factors 1        
Gender           
    Male (reference)        
    Female 1.61 (1.33, 1.94)*** 1.53 (1.26, 1.87)*** --- --- --- --- --- 
Aboriginality          
    Non-Aboriginal 1.65 (1.20, 2.27)** 1.57 (1.10, 2.23)* 1.31 (0.80, 2.15) 1.18 (0.66, 2.1) 1.80 (1.21, 2.70)** 1.85 (1.20, 2.86)** 
0.27 
    Aboriginal (reference)             
Neighbourhood disadvantage              
    Q1 (0%-25%) (most disadvantaged) 1.31 (1.02, 1.68)* 1.38 (1.08, 1.77)** 1.33 (0.92, 1.91) 1.37 (0.96, 1.96) 1.36 (0.99, 1.86) 1.38 (1.02, 1.87)* 
0.06 
    Q2 (25%-50%) 1.06 (0.81, 1.39) 1.08 (0.83, 1.40) 1.36 (0.91, 2.01) 1.37 (0.93, 2.01) 0.95 (0.67, 1.35) 0.95 (0.68, 1.32) 
    Q3 (50%-75%)  1.19 (0.90, 1.57) 1.22 (0.94, 1.59) 0.93 (0.61, 1.41) 0.92 (0.61, 1.39) 1.29 (0.93, 1.79) 1.32 (0.97, 1.80) 
    Q4 (75%-100%) (least disadvantaged - 
reference) 
            
    Trend effect (Q4 to Q1) 1.08 (0.99, 1.17) 1.09 (1.01, 1.19)* 1.13 (1.01, 1.26)* 1.14 (1.02, 1.28)* 1.07 (0.96, 1.19) 1.08 (0.97, 1.20) 0.43 
Remoteness              
    Major cities (reference)             
0.96 
    Inner regional areas 0.90 (0.66, 1.23) 0.87 (0.65, 1.17) 0.95 (0.62, 1.44) 0.93 (0.62, 1.41) 0.89 (0.59, 1.33) 0.84 (0.57, 1.24) 
    Outer regional areas 1.33 (0.90, 1.97) 1.08 (0.73, 1.60) 1.29 (0.72, 2.32) 1.04 (0.56, 1.91) 1.33 (0.82, 2.17) 1.08 (0.66, 1.76) 
    Remote and very remote areas 0.42 (0.23, 0.78)** 0.39 (0.21, 0.73)** 0.48 (0.19, 1.22) 0.47 (0.18, 1.25) 0.41 (0.18, 0.94)* 0.36 (0.16, 0.83)* 
Self-harm method 1               
Non-poisoning (reference)             
<0.001 
Self-poisoning 2 1.02 (0.85, 1.24) 0.93 (0.77, 1.12) 1.47 (1.16, 1.85)** 1.43 (1.12, 1.81)** 0.78 (0.61, 1.00)* 0.78 (0.61, 0.98)* 
    Drug/medication involved 1.63 (1.05, 2.53)* 1.92 (1.25, 2.97)** 1.46 (0.75, 2.83) 1.73 (0.89, 3.36) 1.67 (0.94, 2.99) 2.08 (1.18, 3.66)* 
0.25 
    No drug/medication involved 
(reference) 
            
    Unspecified substance 1.44 (0.77, 2.69) 1.75 (0.98, 3.12) 2.02 (0.78, 5.25) 2.46 (1.01, 5.98)* 1.13 (0.50, 2.53) 1.46 (0.69, 3.07) 
Mental health related factors 1, 3        
Having psychiatric diagnosis within 7 days before and 7 days after an index DSH episode          
    General psychiatric disorders 2.82 (2.42, 3.29)*** 2.73 (2.35, 3.18)*** 2.55 (2.04, 3.20)*** 2.56 (2.03, 3.24)*** 2.83 (2.34, 3.42)*** 2.73 (2.24, 3.31)*** 0.57 
    Substance use disorders 1.76 (1.46, 2.13)*** 1.35 (1.11, 1.65)** 2.48 (1.92, 3.19)*** 1.97 (1.48, 2.63)*** 1.57 (1.21, 2.03)*** 1.08 (0.82, 1.41) <0.01 
    Psychotic disorders 1.60 (1.01, 2.54)* 1.52 (1.00, 2.30) 1.43 (0.94, 2.16) 1.26 (0.82, 1.95) 2.01 (1.01, 4.01)* 1.66 (0.89, 3.09) 0.52 
    Bipolar disorders 1.90 (1.27, 2.85)** 1.33 (0.89, 1.98) 1.88 (0.60, 5.89) 1.49 (0.48, 4.67) 1.73 (1.12, 2.69)* 1.27 (0.83, 1.95) 0.81 
    Depressive disorders 1.82 (1.51, 2.20)*** 1.31 (1.08, 1.58)** 1.77 (1.28, 2.44)*** 1.14 (0.81, 1.61) 1.77 (1.42, 2.20)*** 1.33 (1.07, 1.66)* 0.44 
    Anxiety disorders 1.56 (1.13, 2.16)** 1.38 (1.03, 1.86)* 2.13 (1.26, 3.59)** 1.55 (0.95, 2.53) 1.35 (0.92, 1.99) 1.27 (0.90, 1.81) 0.59 
    Stressor-related disorders 1.97 (1.66, 2.33)*** 1.46 (1.22, 1.74)*** 2.05 (1.57, 2.68)*** 1.68 (1.27, 2.24)*** 1.87 (1.52, 2.29)*** 1.39 (1.12, 1.73)** 0.35 
    Impulse-control disorders 1.92 (1.34, 2.75)*** 1.85 (1.29, 2.64)*** 2.20 (1.19, 4.07)* 2.33 (1.29, 4.22)** 1.85 (1.21, 2.83)** 1.66 (1.07, 2.57)* 0.41 
    Borderline personality disorders 4.21 (3.49, 5.07)*** 3.18 (2.58, 3.92)*** 3.31 (2.45, 4.48)*** 2.29 (1.63, 3.22)*** 4.08 (3.33, 5.00)*** 3.37 (2.67, 4.24)*** 0.05 
DSH episode occurring up to 7 days before an index DSH episode 4      
    No (reference)        
    Yes  3.16 (2.48, 4.03)*** 2.40 (1.91, 3.00)*** 2.10 (1.39, 3.18)** 1.62 (1.06, 2.48)* 3.38 (2.58, 4.43)*** 2.56 (1.98, 3.31)*** 0.06 
1 Adjusted odds ratios (aORs) for all the socio-demographic factors, self-harm method (binary variable taken values as self-poisoning in reference to non-poisoning), and general psychiatric 
disorders (binary variable taken values as having any psychiatric diagnosis in reference to not having any diagnosis) were adjusted in the multivariate regression models including all these 
variables.  
2 Adjusted odds ratios for self-poisoning (categorical variable) were adjusted for all the socio-demographic factors and the binary variable for general psychiatric disorders.  
3 All specific types of psychiatric disorders were treated as binary variables taken values as having a specific type of psychiatric diagnosis in reference to not having the diagnosis. The aORs 
were adjusted for all the socio-demographic factors, the binary variable for self-harm method (taken values as self-poisoning versus non-poisoning), and all the other types of psychiatric 
disorders (binary variables).  
4 Odds ratios for DSH episode occurring within 7 days before the index DSH episode were adjusted for all the socio-demographic factors, the binary variable for self-harm method and the 
binary variable for general psychiatric disorders.  
* p<0.05, ** p<0.01, *** p<0.001   
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Table 3 Gender-specific association between having a repeated DSH episode within the first 7 days after 
an index DSH episode and psychiatric diagnosis within 7 days before and 7 days after an index episode in 
adolescents (10-19 years old) and young adults (20-29 years old) respectively 
Factor1 
Adolescents (10-19 years old) Young adults (20-29 years old) P value2 
OR (95%CI) aOR (95%CI) OR (95%CI) aOR (95%CI) 
All      
    General psychiatric 
disorders 
2.99 (2.29, 3.90)*** 2.79 (2.13, 3.65)*** 2.72 (2.28, 3.25)*** 2.67 (2.24, 3.19)*** 0.95 
    Substance use disorders 1.15 (0.78, 1.68) 0.90 (0.62, 1.31) 1.90 (1.54, 2.34)*** 1.48 (1.19, 1.85)*** 0.02 
    Psychotic disorders 1.65 (0.84, 3.24) 1.18 (0.63, 2.21) 1.47 (0.87, 2.47) 1.44 (0.89, 2.34) 0.64 
    Bipolar disorders 4.28 (2.03, 9.04)*** 2.72 (1.29, 5.71)** 1.41 (0.91, 2.20) 1.03 (0.66, 1.61) 0.11 
    Depressive disorders 2.20 (1.63, 2.98)*** 1.72 (1.23, 2.41)** 1.67 (1.31, 2.12)*** 1.14 (0.92, 1.42) 0.05 
    Anxiety disorders 1.19 (0.61, 2.34) 0.90 (0.52, 1.55) 1.74 (1.23, 2.47)** 1.57 (1.14, 2.17)** 0.06 
    Stressor-related 
disorders 
2.06 (1.59, 2.67)*** 1.67 (1.26, 2.21)*** 1.97 (1.59, 2.44)*** 1.39 (1.11, 1.74)** 
0.42 
    Impulse-control 
disorders 
2.61 (1.74, 3.91)*** 2.55 (1.73, 3.74)*** 0.96 (0.33, 2.74) 0.66 (0.23, 1.94) 
0.01 
    Borderline personality 
disorders 
4.39 (2.98, 6.46)*** 3.24 (2.13, 4.94)*** 3.96 (3.23, 4.85)*** 3.06 (2.43, 3.86)*** 
0.90 
Male      
    General psychiatric 
disorders 
3.55 (2.11, 5.96)*** 3.79 (2.27, 6.32)*** 2.25 (1.74, 2.90)*** 2.24 (1.72, 2.92)*** 0.08 
    Substance use disorders 1.49 (0.79, 2.79) 0.98 (0.54, 1.78) 2.62 (1.98, 3.46)*** 2.24 (1.65, 3.05)*** 0.01 
    Psychotic disorders 0.86 (0.15, 4.89) 0.54 (0.07, 4.35) 1.36 (0.89, 2.09) 1.23 (0.79, 1.91) 0.34 
    Bipolar disorders 12.06 (1.78, 81.80)* 16.97 (1.94, 148.35)* 0.80 (0.25, 2.59) 0.60 (0.17, 2.07) 0.27 
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    Depressive disorders 2.21 (1.12, 4.37)* 1.76 (1.10, 2.82)* 1.58 (1.08, 2.32)* 1.00 (0.64, 1.54) 0.10 
    Anxiety disorders 2.42 (0.47, 12.44) 1.77 (0.68, 4.61) 1.94 (1.10, 3.44)* 1.44 (0.83, 2.49) 0.75 
    Stressor-related 
disorders 
2.58 (1.50, 4.45)*** 2.31 (1.42, 3.76)*** 1.89 (1.38, 2.59)*** 1.54 (1.10, 2.16)* 
0.19 
    Impulse-control 
disorders 
3.97 (1.87, 8.40)*** 3.91 (2.29, 6.67)*** 0.63 (0.09, 4.31) 0.47 (0.06, 3.93) 
0.01 
    Borderline personality 
disorders 
2.87 (1.32, 6.21)** 2.36 (1.39, 4.02)** 3.33 (2.33, 4.74)*** 2.31 (1.52, 3.52)*** 
0.96 
Female      
    General psychiatric 
disorders 
2.69 (1.97, 3.67) *** 2.46 (1.80, 3.37)*** 2.88 (2.29, 3.63)*** 2.86 (2.25, 3.63)*** 0.30 
    Substance use disorders 1.09 (0.68, 1.75) 0.79 (0.48, 1.30) 1.65 (1.25, 2.19)*** 1.16 (0.87, 1.55) 0.17 
    Psychotic disorders 2.13 (1.07, 4.26)* 1.29 (0.69, 2.43) 1.85 (0.81, 4.19) 1.64 (0.78, 3.43) 0.62 
    Bipolar disorders 3.28 (1.42, 7.59)** 2.02 (0.97, 4.24) 1.35 (0.82, 2.22) 1.10 (0.68, 1.77) 0.26 
    Depressive disorders 2.07 (1.48, 2.89)*** 1.62 (1.11, 2.38)* 1.63 (1.22, 2.17)*** 1.19 (0.93, 1.54) 0.19 
    Anxiety disorders 0.92 (0.46, 1.85) 0.72 (0.40, 1.32) 1.63 (1.08, 2.48)* 1.54 (1.04, 2.28)* 0.03 
    Stressor-related 
disorders 
1.88 (1.40, 2.52)*** 1.56 (1.13, 2.15)** 1.91 (1.47, 2.49)*** 1.35 (1.03, 1.78)* 
0.65 
    Impulse-control 
disorders 
2.28 (1.42, 3.65)*** 2.00 (1.24, 3.25)** 1.74 (0.55, 5.46) 0.89 (0.25, 3.24) 
0.21 
    Borderline personality 
disorders 
4.34 (2.87, 6.56)*** 3.41 (2.15, 5.40)*** 3.76 (2.98, 4.75)*** 3.17 (2.44, 4.11)*** 
0.84 
1 Psychiatric disorders (including general and all specific types) were treated as binary variables taken values as 
having any or a specific type of psychiatric diagnosis in reference to not having the corresponding diagnosis. The 
adjusted odds ratios (aORs) were adjusted for all the socio-demographic factors and the binary variable for self-harm 
method (taken values as self-poisoning versus Non-poisoning). For each specific type of psychiatric disorder, the 
aOR was further adjusted for all other types of psychiatric disorders. 
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2 P value for the significance of the difference between the aOR for adolescents and young adults 






Supplementary Table 1 ICD-10-AM codes for DSH method and major types of psychiatric disorders 
DSH and Psychiatric disorders ICD-10-AM1 
Deliberate self-harm and self-harm methods  
Deliberate self-harm X60-X84, Y10-Y34 
    No self-poisoning X70-X84, Y20-Y34 
    Self-poisoning X60-X69, Y10-Y19 
        Self-poisoning with drug (mainly drug and medicament) X60-X64, Y10-Y14 
             Non-illicit drug X60, X61, X63, Y10, Y11, Y13 
             Illicit drug X62, Y12 
             Unspecified drug X64, Y14 
        Self-poisoning with other substance (chiefly non-medicinal 
as to source, including alcohol) 
X65-X68, Y15-Y18 
        Self-poisoning with unspecified substance X69, Y19 
Psychiatric disorders  
All types of psychiatric disorders F01-F99 
Substance use disorders  F10-F19, F55 
Psychotic disorders  F20-F29 
Bipolar disorders F30, F31. F34.0 
Depressive disorders F32-F39 (excl. F34.0) 
Anxiety disorders  F40-F42, F93.(1,2) 
Stressor-related disorders (e.g. posttraumatic stress disorders) F43, F93.0, F94.(0,1,2) 
Impulse-control disorders (e.g. attention deficit/hyperactivity 
disorders, conduct disorder) 
F90-F92 
Borderline personality disorder (BPD) F60.3 
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1 ICD-10-AM refers to International Statistical Classification of Diseases and Related Health Problems, 10 th 
Revision, Australian Modification 
Supplementary Table 2 Incidence of repeated DSH episodes by type of episode (by admission date) 
Type of episode and 





Number of repeated DSH episodes 
within the first seven days (%) 
Number of 
repeated DSH 






date as the starting 
point 
Discharge/separation 
date as the starting 
point 
All episodes  16,966 1,245 (7.34) 1,280 (7.54) --- 
Emergency department 
episodes 
13,336 902 (6.76) 902 (6.76) --- 
Hospital inpatient 
episodes 
3,595  336 (9.35) 371 (10.32) 66 
Length of stay in a hospital inpatient episode (days)   
0-1 1,944 183 (9.41) 189 (9.72) 3 
2-3 588 79 (13.44) 72 (12.24) 15 
4-7 395 41 (10.38) 52 (13.16) 15 
8-14 310 14 (4.52) 26 (8.39) 14 
15-30 207 8 (3.86) 20 (9.66) 8 
31-60 106 8 (7.55) 8 (7.55) 8 
61-90 26 3 (11.54) 4 (15.38) 3 
90+ 19 0 (0.00) 0 (0.00) 0 
Note: The remaining 35 valid DSH episodes were identified in MHIS data. 
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For emergency department episodes or the transfer-bonded episode pairs (i.e. an emergency episode followed by a 
transfer to a hospital inpatient care), we used the “presentation date” of the emergency episodes as the starting time 
point to determine the seven-day window for repetition. For the hospital inpatient episodes, we used the “admission 
date”, rather than the discharge date. This is because we specifically focused on a patient’s risk at the time of a DSH 
episode, rather than the risk after a period of stay in hospital inpatient care. Furthermore, Supplementary Table 2 
shows that a repeated DSH behaviour could occur during an episode of inpatient care (the last column), and these 
repeated DSH episodes would not be identified if separation date were used as the starting time point.  
For hospital inpatient episodes, we identified more repeated DSH episodes by using separation date as the starting 
time point to identify the seven-day window for repetition, compared to admission date (see 3rd and 4th columns). 
This was particularly noticeable for the episodes where the length of stay was greater than a week but less than a 
month (e.g. 8-30 days). Such a pattern may suggest that the risk of repeating a DSH behaviour within the following 
seven days is more likely determined by certain risk factors that were present at the time of the index DSH episode, 
rather than related to the length of stay in a hospital inpatient care (at least less than a month). 
 
 
 
 
